“Nuclear-Targeted Engineering of a Lunasin-Derived Peptide Enhances Antiproliferative Activity and AP-1-Associated Gene Modulation in A549 Lung Cancer Cells”. Al Mustansiriyah Journal of Pharmaceutical Sciences, vol. 26, no. 3, Sept. 2026, pp. 331-53, https://doi.org/10.32947/ajps.v26i3.1404.